The body can synthesise it from methionine and lysine
Individualized dosing, regular laboratory monitoring (particularly IGF-1 levels), and physician oversight are key to maintaining safety and optimizing therapeutic benefit
Within which mitochondrial compartment melatonin is produced is still under debate
Altered daytime fluctuation pattern of plasminogen activator inhibitor 1 in type 2 diabetes patients with coronary artery disease: a strong association with persistently elevated plasma insulin, increased insulin resistance, and abdominal obesity
Yet another challenge in implementing KD is its proper nutritional balancing
Adv Drug Delivery Rev 42:225238 Lewis AL, Mcentee N, Holland J, Patel A (2022) Development and approval of rybelsus (oral semaglutide): ushering in a new era in peptide delivery